Appetite-suppressant drugs and the risk of primary pulmonary hypertension

New England Journal of Medicine

Volumn 335, Issue 9, 1996, Pages 609-616

  Abenhaim, Lucien ^a   Moride, Yola ^a   Brenot, François ^b   Rich, Stuart ^c   Benichou, Jacques ^d   Kurz, Xavier ^e   Higenbottam, Tim ^f   Oakley, Celia ^g   Wouters, Emil ^h   Aubier, Michel ⁱ   Simonneau, Gérald ^b   Bégaud, Bernard ^j  

^a MCGILL UNIVERSITY   (Canada)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e UNIVERSITY OF LIÈGE   (Belgium)

^f UNIVERSITY OF SHEFFIELD   (United Kingdom)

^g HAMMERSMITH HOSPITAL   (United Kingdom)

^h MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ BICHAT HOSPITAL   (France)

^j HÔPITAL PELLEGRIN   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMFEPRAMONE; ANOREXIGENIC AGENT; CLOBENZOREX; DEXFENFLURAMINE; FENFLURAMINE; FENPROPOREX; PHENMETRAZINE;

ADOLESCENT; ADULT; AGED; APPETITE DISORDER; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ABUSE; FAMILY HISTORY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; APPETITE DEPRESSANTS; BELGIUM; CASE-CONTROL STUDIES; FEMALE; FENFLURAMINE; FRANCE; GREAT BRITAIN; HEART FUNCTION TESTS; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PULMONARY; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; RESPIRATORY FUNCTION TESTS; RISK FACTORS;

EID: 9444287592     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199608293350901     Document Type: Article

References (27)

1. Rubin LJ. Primary pulmonary hypertension. Chest 1993;104:236-50.
2. Rich S, Dantzker DR, Ayres SM, et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987;107:216-23.
3. Langleben D. Familial primary pulmonary hypertension. Chest 1994; 105:Suppl:13S-16S.
4. Hadengue A, Benhayoun MK, Lebrec D, Benhamou JP. Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 1991;100:520-8.
5. McDonnell PJ, Toye PA, Hutchins GM. Primary pulmonary hypertension and cirrhosis: are they related? Am Rev Respir Dis 1983;127:437-41.
6. Dawkins KD, Burke CM, Billingham ME, Jamieson SW. Primary pulmonary hypertension and pregnancy. Chest 1986;89:383-8.
7. Collins E, Hardwick H, Jeftery H. Perinatal cocaine intoxication. Med. J Aust 1989;150:331-2.
8. Legoux B, Piette AM, Bouchet PE, Laudau JF, Gepner P, Chapman AM. Pulmonary hypertension and HIV infection. Am J Med 1990;89:122.
9. Klciger RE, Boxer M, Ingham RE, Harrison DC. Pulmonary hypertension in patients using oral contraceptives: a report of six cases. Chest 1976; 69:143-7.
10. Masi AT. Pulmonary hypertension and oral contraceptive usage. Chest 1976;69:451-3.
11. Gurtner HP. Aminorcx and pulmonary hypertension. Cor Vasa 1985; 27:160-71.
12. Douglas JG, Munro JF, Kitchin AH, Muir AL, Proudfoot AT. Pulmonary hypertension and fenfluramine. BMJ 1981;283:881-3.
13. Brenot F, Herve P, Petitpretz P, Parent F, Duroux P, Simonneau G. Primary pulmonary hypertension and fenfluramine use. Br Heart J 1993;70: 537-41.
14. Abenhaim L. The International Primary Pulmonary Hypertension Study (IPPHS). Chest 1994;105:Suppl:37S-41S.
15. Brenot F. Primary pulmonary hypertension: case series from France. Chest 1994;105:Suppl:33S-36S.
16. McMurray J, Bloomfield P, Miller HC. Irreversible pulmonary hypertension after treatment with fenfluramine. BMJ 1986;293:51-2.
17. Pouwels HM, Smeets JL, Cheriex EC, Wouters EF. Pulmonary hypertension and fenfluramine. Eur Respir J 1990;3:606-7.
18. Fahlen M, Bergman H, Helder G, Ryden L, Wallentin I, Zettergren L. Phenformin and pulmonary hypertension. Br Heart J 1973;35:824-8.
19. Hervé P, Launay J-M, Scrobohaci M-L, et al. Increased plasma serotonin in primary pulmonary hypertension. Am J Med 1995;99:249-54.
20. Michelakis ED, Archer SL, Huang JMC, Nelson DP, Weir EK. Anorexic agents inhibit potassium current in pulmonary artery smooth muscle cells. Am J Respir Crit Care Med 1995;151:Suppl:A725. abstract.
21. Naeije R, Wauthy P, Maggiorini M, Leeman M, Delcroix M. Effects of dexfenfluramine on hypoxic pulmonary vasoconstriction and embolic pulmonary hypertension in dogs. Am J Respir Crit Care Med 1995;151: 692-7.
22. Oakley CW. Primary pulmonary hypertension: case series from the United Kingdom. Chest 1994;105:Suppl:29S-32S.
23. Rubin LJ, Mendoza J, Hood M, et al. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol): results of a randomized trial. Ann Intern Med 1990;112:485-91.
24. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;327:76-81.
25. Petitpretz P, Brenot F, Azarian R, et al. Pulmonary hypertension in patients with human immunodeficiency virus infection: comparison with primary pulmonary hypertension. Circulation 1994;89:2722-7.
26. Russel LA, Spehlmann JC, Clarke M, Lillington GA. Pulmonary hypertension in female crack users. Am Rev Respir Dis 1992;145:Suppl:A717. abstract.
27. Schaiberger PH, Kennedy TC, Miller FC, Gal J, Petty TL. Pulmonary hypertension associated with long-term inhalation of "crank" methamphetamine. Chest 1993;104:614-6.